CTOs on the Move

Astute Medical

www.astutemedical.com

 
Astute Medical is committed to improving patient outcomes through the identification and validation of unique biomarkers. Our measurement methods help rapidly assess high-risk acute conditions and diseases. By incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.astutemedical.com
  • 3550 General Atomics Court Building 02/620
    San Diego, CA USA 92121
  • Phone: 858.500.7000

Executives

Name Title Contact Details

Funding

Astute Medical raised $20M on 10/14/2015
Astute Medical raised $43M on 12/17/2016

Similar Companies

Nowak Dental Supplies

Nowak Dental Supplies is a Carriere, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Annex Ventures

Annex Ventures is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LensCrafters

LensCrafters is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

American Academy of Urgent Care Medicine

American Academy of Urgent Care Medicine is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endologix

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.